Guided Therapeutics (GTHP) Current Deferred Tax Assets (2012 - 2016)
Guided Therapeutics (GTHP) posted Current Deferred Tax Assets of $795000.0 for Q4 2016, up 27.0% sequentially from $626000.0 in Q4 2015, and up 27.0% YoY from $626000.0 in Q1 2016.
Guided Therapeutics (GTHP) Current Deferred Tax Assets (2012 - 2016) Analysis & Trends
Guided Therapeutics has reported Current Deferred Tax Assets for 5 years, with the latest figure at $795000.0 in Q4 2016.
- Quarterly Current Deferred Tax Assets rose 27.0% year-over-year to $795000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $795000.0 (up 27.0% YoY) and the FY2016 annual result came in at $795000.0, up 27.0% from the prior year.
- Current Deferred Tax Assets grew to $795000.0 in Q4 2016 per GTHP's latest filing, from $626000.0 in the prior quarter.
- Over five years, Current Deferred Tax Assets peaked at $795000.0 in Q4 2016 and troughed at $277000.0 in Q4 2012.
- A 5-year average of $490200.0 and a median of $466000.0 in 2014 frame the typical range for Current Deferred Tax Assets.
- The sharpest annual moves came in 2013 and 2014: Current Deferred Tax Assets increased 3.61% in 2013, then soared 62.37% in 2014.
- Over 5 years, Current Deferred Tax Assets stood at $277000.0 in 2012, then grew by 3.61% to $287000.0 in 2013, then jumped by 62.37% to $466000.0 in 2014, then surged by 34.33% to $626000.0 in 2015, then advanced by 27.0% to $795000.0 in 2016.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $795000.0, $626000.0, and $466000.0 for Q4 2016, Q4 2015, and Q4 2014 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 795,000.00 |
| Dec 31, 2016 | 795,000.00 |
| Dec 31, 2015 | 626,000.00 |
| Dec 31, 2015 | 626,000.00 |
| Dec 31, 2014 | 466,000.00 |
| Dec 31, 2014 | 466,000.00 |
| Dec 31, 2013 | 287,000.00 |
| Dec 31, 2013 | 287,000.00 |
| Dec 31, 2012 | 277,000.00 |
| Dec 31, 2012 | 277,000.00 |